In 2014, Howmedica Osteonics Corporation, a subsidiary of Stryker Orthopaedics, agreed to a $1 billion global settlement to address thousands of claims related to injuries caused by faulty hip implant parts.
Thousands of Hip Implant Cases
Howmedica/Stryker faced thousands of cases in the U.S. related to its Rejuvenate and ABG II modular hip implant. In July 2012, the companies recalled their products due to reports of abnormally high rates of device failures.
Beasley Allen attorney Navan Ward was a part of the consolidated hip implant cases against the companies.
“Our attorneys, along with many others across the country, pushed this litigation on multiple fronts to hold the companies accountable and to provide our clients with the much-needed compensation they deserve,” said Ward. “Many of our clients have suffered catastrophic damage to their hip and femur areas due to the highly invasive nature of these hip devices, resulting in the need for revision surgeries. Such injuries are often permanent.”
Invasive Revision Surgeries, Metallosis
Approximately 20,000 Americans received Rejuvenate and ABG II hip implants. Revision surgery can cause further instability in the hip and femur, with more severe damage than other metal-on-metal hip implant failures. Patients reported issues as soon as two years after receiving these implants due to metal debris buildup, leading to metal poisoning or metallosis.
The settlement was overseen by Judge Brian R. Martinotti from the Superior Court of New Jersey and Judge Donovan W. Frank from the U.S. District of Minnesota.